Polycystin-1: a master regulator of intersecting cystic pathways.

Abstract:

:Autosomal dominant polycystic kidney disease (ADPKD) is the most common potentially lethal monogenic disorder, with more than 12 million cases worldwide. The two causative genes for ADPKD, PKD1 and PKD2, encode protein products polycystin-1 (PC1) and polycystin-2 (PC2 or TRPP2), respectively. Recent data have shed light on the role of PC1 in regulating the severity of the cystic phenotypes in ADPKD, autosomal recessive polycystic kidney disease (ARPKD), and isolated autosomal dominant polycystic liver disease (ADPLD). These studies showed that the rate for cyst growth was a regulated trait, a process that can be either sped up or slowed down by alterations in functional PC1. These findings redefine the previous understanding that cyst formation occurs as an 'on-off' process. Here, we review these and other related studies with an emphasis on their translational implications for polycystic diseases.

journal_name

Trends Mol Med

authors

Fedeles SV,Gallagher AR,Somlo S

doi

10.1016/j.molmed.2014.01.004

subject

Has Abstract

pub_date

2014-05-01 00:00:00

pages

251-60

issue

5

eissn

1471-4914

issn

1471-499X

pii

S1471-4914(14)00005-7

journal_volume

20

pub_type

杂志文章,评审
  • Loss of autoimmune T cells correlates with brain diseases: possible implications for schizophrenia?

    abstract::T-cell-mediated autoimmunity participates in physiological defense, maintenance and repair of the adult brain. However, unless such autoimmune responses to insults are rigorously controlled, they might lead to an autoimmune disease or other immune-related defects, where destructive activity outweighs the beneficial ef...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2006.01.003

    authors: Kipnis J,Cardon M,Strous RD,Schwartz M

    更新日期:2006-03-01 00:00:00

  • Protein S-nitrosylation in health and disease: a current perspective.

    abstract::Protein S-nitrosylation constitutes a large part of the ubiquitous influence of nitric oxide on cellular signal transduction and accumulating evidence indicates important roles for S-nitrosylation both in normal physiology and in a broad spectrum of human diseases. Here we review recent findings that implicate S-nitro...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2009.06.007

    authors: Foster MW,Hess DT,Stamler JS

    更新日期:2009-09-01 00:00:00

  • Signaling to NF-kappaB by Toll-like receptors.

    abstract::Innate immunity is the first line of defense against invading pathogens. A family of Toll-like receptors (TLRs) acts as primary sensors that detect a wide variety of microbial components and elicit innate immune responses. All TLR signaling pathways culminate in activation of the transcription factor nuclear factor-ka...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2007.09.002

    authors: Kawai T,Akira S

    更新日期:2007-11-01 00:00:00

  • The immunomodulatory capacity of mesenchymal stem cells.

    abstract::Mesenchymal stem cells (MSCs) are currently being tested in clinical trials for the treatment of various diseases owing to the ease of generating and expanding these cells, the ability to differentiate them into various specialized mesenchymal tissue types and their immunosuppressive properties. However, their immunom...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2011.10.004

    authors: Gebler A,Zabel O,Seliger B

    更新日期:2012-02-01 00:00:00

  • Modulating Antibody Functionality in Infectious Disease and Vaccination.

    abstract::Induction of pathogen-specific binding antibodies has long been considered a signature of protective immunity following vaccination and infection. The humoral immune response is a complex network of antibodies that target different specificities and drive different functions, collectively acting to limit and clear inf...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2016.09.002

    authors: Gunn BM,Alter G

    更新日期:2016-11-01 00:00:00

  • Strategies to Identify Genetic Variants Causing Infertility.

    abstract::Genetic causes are thought to underlie about half of infertility cases, but understanding the genetic bases has been a major challenge. Modern genomics tools allow more sophisticated exploration of genetic causes of infertility through population, family-based, and individual studies. Nevertheless, potential therapies...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2020.12.008

    authors: Ding X,Schimenti JC

    更新日期:2021-01-08 00:00:00

  • Tools for Bioimaging Pancreatic β Cells in Diabetes.

    abstract::When diabetes is diagnosed, the majority of insulin-secreting pancreatic β cells are already dysfunctional or destroyed. This β cell dysfunction/destruction usually takes place over many years, making timely detection and clinical intervention difficult. For this reason, there is immense interest in developing tools t...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2019.05.004

    authors: Kang NY,Soetedjo AAP,Amirruddin NS,Chang YT,Eriksson O,Teo AKK

    更新日期:2019-08-01 00:00:00

  • RBC NOS: regulatory mechanisms and therapeutic aspects.

    abstract::Nitric oxide (NO), one of the most important vascular signaling molecules, is primarily produced by endothelial NO synthase (eNOS). eNOS is tightly regulated by its substrate l-arginine, cofactors and diverse interacting proteins. Interestingly, an NO synthase (NOS) was described within red blood cells (RBC NOS), and ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2008.05.002

    authors: Ozüyaman B,Grau M,Kelm M,Merx MW,Kleinbongard P

    更新日期:2008-07-01 00:00:00

  • Immunotherapy: target the stroma to hit the tumor.

    abstract::For decades it has been assumed that T cells reject tumors essentially by direct killing. However, solid tumors are composed of malignant cells and a variety of different nonmalignant cells, referred to as tumor stroma. Stromal cells, such as endothelial cells, fibroblasts and inflammatory cells, often support tumor g...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2005.03.002

    authors: Kammertoens T,Schüler T,Blankenstein T

    更新日期:2005-05-01 00:00:00

  • iPSCs for personalized medicine: what will it take for Africa?

    abstract::Induced pluripotent stem cells (iPSCs) are cutting edge biotechnology that may revolutionize medicine, and creating iPSCs from ethnically diverse individuals would generate valuable therapeutic and drug development tools. However, challenges must be overcome in creating the infrastructure and scientific capacity neede...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2012.10.005

    authors: Fakunle ES

    更新日期:2012-12-01 00:00:00

  • Putting the brakes on anticancer therapies: suppression of innate immune pathways by tumor-associated myeloid cells.

    abstract::Accumulating evidence has revealed that immunogenic cell death triggered by particular chemotherapeutic agents plays a critical role in harnessing antitumor immunity to clinical responses. However, negative regulatory pathways exist which suppress the induction of effective immune responses by a broad spectrum of anti...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2013.06.001

    authors: Jinushi M,Yagita H,Yoshiyama H,Tahara H

    更新日期:2013-09-01 00:00:00

  • mTOR: A pathogenic signaling pathway in developmental brain malformations.

    abstract::The mTOR signaling network functions as a pivotal regulatory cascade during the development of the cerebral cortex. Aberrant hyperactivation of mTOR as a consequence of loss-of-function gene mutations encoding mTOR inhibitor proteins such as TSC1, TSC2, PTEN and STRADα has been recently linked to developmental cortica...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2011.07.008

    authors: Crino PB

    更新日期:2011-12-01 00:00:00

  • Huntington's Disease: Les Jeux Sont Faits?

    abstract::In a meticulous study, Humbert, Durr, and colleagues showed evidence for aberrant neurodevelopment in both Huntington's disease (HD) and mouse models of HD. We consider the implications of prenatal pathological changes for the onset and progression of HD and their relatedness to current therapeutic plans. ...

    journal_title:Trends in molecular medicine

    pub_type: 评论,杂志文章

    doi:10.1016/j.molmed.2020.08.004

    authors: Pfister EL,Aronin N

    更新日期:2020-10-01 00:00:00

  • Advances in epigenome-wide association studies for common diseases.

    abstract::Epigenome-wide association studies (EWASs) provide a systematic approach to uncovering epigenetic variants underlying common diseases. Discoveries have shed light on novel molecular mechanisms of disease and enabled the application of epigenetic variants as biomarkers. Here, we highlight the recent advances in this em...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2014.07.002

    authors: Paul DS,Beck S

    更新日期:2014-10-01 00:00:00

  • 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications.

    abstract::H(2)O(2) is a reactive oxygen species that has drawn much interest because of its role as a second messenger in receptor-mediated signaling. Mammalian 2-Cys peroxiredoxins have been shown to eliminate efficiently the H(2)O(2) generated in response to receptor stimulation. 2-Cys peroxiredoxins are members of a novel pe...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2005.10.006

    authors: Kang SW,Rhee SG,Chang TS,Jeong W,Choi MH

    更新日期:2005-12-01 00:00:00

  • Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA.

    abstract::Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system. The inflammatory and neurodegenerative pathways driving MS are modulated by DNA, lysine, and arginine methylation, as evidenced by studies made possible by novel tools for methylation detection or loss of function. We present evid...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2017.04.004

    authors: Webb LM,Guerau-de-Arellano M

    更新日期:2017-06-01 00:00:00

  • MicroRNA Regulators of Anxiety and Metabolic Disorders.

    abstract::Anxiety-related and metabolic disorders are under intense research focus. Anxiety-induced microRNAs (miRNAs) are emerging as regulators that are not only capable of suppressing inflammation but can also induce metabolic syndrome-related processes. We summarize here evidence linking miRNA pathways which share regulator...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2016.07.001

    authors: Meydan C,Shenhar-Tsarfaty S,Soreq H

    更新日期:2016-09-01 00:00:00

  • Hepatitis C: molecular virology and antiviral targets.

    abstract::Chronic hepatitis C is a leading cause of liver cirrhosis and hepatocellular carcinoma worldwide. Although current treatment options are limited, progress in understanding the molecular virology of hepatitis C has led to the identification of novel antiviral targets. Moreover, in vitro and in vivo model systems have b...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4914(02)02395-x

    authors: Moradpour D,Brass V,Gosert R,Wölk B,Blum HE

    更新日期:2002-10-01 00:00:00

  • Protein transport into the endoplasmic reticulum: mechanisms and pathologies.

    abstract::Transport into the endoplasmic reticulum (ER) is the crucial step in the biosynthesis of most secretory proteins and many membrane proteins. The products of the SIL1, SEC62 and SEC63 genes act in concert with the SEC61 complex and the molecular chaperones BiP and GRP170 to transport proteins into the ER. Interestingly...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2006.10.004

    authors: Zimmermann R,Müller L,Wullich B

    更新日期:2006-12-01 00:00:00

  • Glutamine Skipping the Q into Mitochondria.

    abstract::Imported across the plasma membrane by SLC1A5, glutamine has emerged as a metabolic fuel that is catabolized by mitochondrial glutaminase to support tumor growth. The missing link between cytoplasmic and mitochondrial glutamine metabolism is now provided by Yoo et al., identifying the mitochondrial glutamine importer ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2019.11.004

    authors: Stine ZE,Dang CV

    更新日期:2020-01-01 00:00:00

  • Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

    abstract::While preclinical studies have reported improvement of behavioral deficits in the Ts65Dn mouse model of Down syndrome (DS), translation to human clinical trials to improve cognition in individuals with DS has had a poor success record. Timing of the intervention, choice of animal models, strategy for drug selection, a...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2019.10.001

    authors: Lee SE,Duran-Martinez M,Khantsis S,Bianchi DW,Guedj F

    更新日期:2020-02-01 00:00:00

  • Molecular targeting of glioblastoma: Drug discovery and therapies.

    abstract::Despite advances in treatment for glioblastoma multiforme (GBM), patient prognosis remains poor. Although there is growing evidence that molecular targeting could translate into better survival for GBM, current clinical data show limited impact on survival. Recent progress in GBM genomics implicate several activated p...

    journal_title:Trends in molecular medicine

    pub_type: 临床试验,杂志文章,评审

    doi:10.1016/j.molmed.2011.01.011

    authors: Bai RY,Staedtke V,Riggins GJ

    更新日期:2011-06-01 00:00:00

  • The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.

    abstract::Ubiquitin-containing cellular inclusions are characteristic of major neurodegenerative diseases and suggest an involvement of the ubiquitin-proteasome system. The frameshifted form of ubiquitin has proved to be a valuable tool for studying the role of the ubiquitin-proteasome system. It is an endogenous reporter for p...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2005.09.001

    authors: Hol EM,van Leeuwen FW,Fischer DF

    更新日期:2005-11-01 00:00:00

  • Do Microglial Sex Differences Contribute to Sex Differences in Neurodegenerative Diseases?

    abstract::Sex differences have been clinically documented in numerous neurodegenerative diseases and yet the reasons for these differences are not well understood. Recent studies have found that microglia, the innate immune cells of the central nervous system, are a key cell type involved in neurodegenerative diseases. This cel...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2019.05.001

    authors: Kodama L,Gan L

    更新日期:2019-09-01 00:00:00

  • HIF-1 and tumor progression: pathophysiology and therapeutics.

    abstract::Hypoxia-inducible factor 1 (HIF-1) controls oxygen delivery (via angiogenesis) and metabolic adaptation to hypoxia (via glycolysis). HIF-1 consists of a constitutively expressed HIF-1 beta subunit and an oxygen- and growth-factor-regulated HIF-1 alpha subunit. In xenografts, tumor growth and angiogenesis are correlate...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4914(02)02317-1

    authors: Semenza GL

    更新日期:2002-01-01 00:00:00

  • Protein kinase A as a therapeutic target for memory disorders: rationale and challenges.

    abstract::cAMP-dependent protein kinase A (PKA) signaling has a key role in memory processes and has been identified as a potential therapeutic target for memory disorders. The activation of PKA signaling is crucial for the consolidation of long-term memories dependent on the hippocampus and/or the amygdala, By contrast, initia...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2005.01.006

    authors: Arnsten AF,Ramos BP,Birnbaum SG,Taylor JR

    更新日期:2005-03-01 00:00:00

  • Early Detection of Cancer in Blood Using Single-Cell Analysis: A Proposal.

    abstract::Here, we explore the potential of single-cell genomic analysis in blood for early detection of cancer; we consider a method that screens the presence of recurrent patterns of copy number (CN) alterations using sparse single-cell sequencing. We argue for feasibility, based on in silico analysis of existing single-cell ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2017.05.005

    authors: Krasnitz A,Kendall J,Alexander J,Levy D,Wigler M

    更新日期:2017-07-01 00:00:00

  • Recurrent pregnancy loss: the key potential mechanisms.

    abstract::Recurrent pregnancy loss (RPL), which occurs in 0.5%-1% of total pregnancies, is usually defined as three or more consecutive spontaneous abortions before 20 weeks of gestation. Although an immunology-based etiology underlying unexplained RPL has been demonstrated, the exact molecular mechanisms are still poorly under...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2007.05.005

    authors: Baek KH,Lee EJ,Kim YS

    更新日期:2007-07-01 00:00:00

  • Wound Repair, Scar Formation, and Cancer: Converging on Activin.

    abstract::Wound repair is a highly regulated process that requires the interaction of various cell types. It has been shown that cancers use the mechanisms of wound healing to promote their own growth. Therefore, it is of importance to identify common regulators of wound repair and tumor formation and to unravel their functions...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2020.07.009

    authors: Cangkrama M,Wietecha M,Werner S

    更新日期:2020-12-01 00:00:00

  • Immune Checkpoint Molecules, Personalized Immunotherapy, and Autoimmune Diabetes.

    abstract::Although significant progress has been made in understanding autoimmunity, no immunotherapy to effectively halt immune-mediated destruction of β cells in type 1 diabetes (T1D) is currently available. For successful immunotherapy it will be necessary to identify novel drug targets as well as robust immunologic biomarke...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2018.08.005

    authors: Orabona C,Mondanelli G,Puccetti P,Grohmann U

    更新日期:2018-11-01 00:00:00